Soluble Aβ oligomer production and toxicity

Megan E. Larson, Sylvain E. Lesné

Research output: Contribution to journalReview articlepeer-review

273 Scopus citations

Abstract

For nearly 100 years following the first description of this neurological disorder by Dr Alois Alzheimer, amyloid plaques and neurofibrillary tangles have been hypothesized to cause neuronal loss. With evidence that the extent of insoluble, deposited amyloid poorly correlated with cognitive impairment, research efforts focused on soluble forms of Aβ, also referred as Aβ oligomers. Following a decade of studies, soluble oligomeric forms of Aβ are now believed to induce the deleterious cascade(s) involved in the pathophysiology of Alzheimer's disease. In this review, we will discuss our current understanding about endogenous oligomeric Aβ production, their relative toxicity in vivo and in vitro, and explore the potential future directions needed for the field.

Original languageEnglish (US)
Pages (from-to)125-139
Number of pages15
JournalJournal of Neurochemistry
Volume120
Issue numberSUPPL. 1
DOIs
StatePublished - Jan 2012

Keywords

  • Alzheimer's disease
  • amyloid-beta
  • oligomer
  • transgenic mouse

Fingerprint Dive into the research topics of 'Soluble Aβ oligomer production and toxicity'. Together they form a unique fingerprint.

Cite this